Publications by authors named "Shigeto Ueda"

Claim this Profile
I
Invasive carcinoma with neuroendocrine differentiation of the breast showing triple negative, large and basal cell-like features.
Tomonori Kawasaki, Takahiro Hasebe, Mikinao Oiwa, Keiji Sugiyama, Chisako Muramatsu, Shigeto Ueda

Pathol Int· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693).
Aya Asano, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane, Hideki Takeuchi

Breast Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular hypoxia measured by F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer.
Aya Asano, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane, Hideki Takeuchi

Breast Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-Fluoroestradiol PET/CT Correctly Diagnosed 18F-FDG-Avid Inflammatory Lymph Nodes in a Patient With Estrogen Receptor-Positive Breast Cancer.
Tomohiko Yamane, Shigeto Ueda, Akira Seto, Ichiei Kuji

Clin Nucl Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety.
Ikuko Sugitani, Shigeto Ueda, Takashi Sakurai, Takashi Shigekawa, Eiko Hirokawa

Int J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab Induces Acute Hypoxia and Cancer Progression in Patients with Refractory Breast Cancer: Multimodal Functional Imaging and Multiplex Cytokine Analysis.
Shigeto Ueda, Toshiaki Saeki, Akihiko Osaki, Tomohiko Yamane, Ichiei Kuji

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast.
Hiroko Shimada, Takahiro Hasebe, Michiko Sugiyama, Satomi Shibasaki, Ikuko Sugitani, Shigeto Ueda

Pathol Int· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: A pilot study to evaluate the feasibility of the method.
Shintaro Nakano, Masahiro Takahashi, Fumiko Kimura, Taiki Senoo, Toshiaki Saeki, Shigeto Ueda

Cardiol J· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.
Hirofumi Mukai, Toshiaki Saeki, Kenjiro Aogi, Yoichi Naito, Nobuaki Matsubara, Shigeto Ueda

Cancer Sci· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Shigeto Ueda, Nobuko Yoshizawa, Takashi Shigekawa, Hideki Takeuchi, Hiroyuki Ogura, Yukio Ueda

J Nucl Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab.
Shigeto Ueda, Toshiaki Saeki, Hideki Takeuchi, Takashi Shigekawa, Tomohiko Yamane

Br J Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
Hiroko Shimada, Shigeto Ueda, Toshiaki Saeki, Takashi Shigekawa, Hideki Takeuchi

Jpn J Clin Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
Michiko Sugiyama, Takahiro Hasebe, Hiroko Shimada, Hideki Takeuchi, Kyoko Shimizu, Shigeto Ueda

Hum Pathol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.
Takashi Shigekawa, Akihiko Osaki, Hiroshi Sekine, Nobuaki Sato, Chizuko Kanbayashi, Shigeto Ueda

BMC Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.
Shigeto Ueda, Ichiei Kuji, Takashi Shigekawa, Hideki Takeuchi, Hiroshi Sano

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy.
Shigeto Ueda, Toshiaki Saeki

Breast Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy.
Noriko Nakamiya, Shigeto Ueda, Takashi Shigekawa, Hideki Takeuchi, Hiroshi Sano

Cancer Sci· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast.
Shigeto Ueda, Noriko Nakamiya, Kazuo Matsuura, Takashi Shigekawa, Hiroshi Sano

BMC Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling shows increased glucose metabolism in luminal B breast cancer.
Shigeto Ueda, Toshiaki Saeki, Hideki Takeuchi, Takashi Shigekawa, Kazuo Matsuura

J Breast Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.
Shigeto Ueda, Darren Roblyer, Albert Cerussi, Amanda Durkin, Anais Leproux

Cancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response.
Shigeto Ueda, Toshiaki Saeki, Takashi Shigekawa, Jiro Omata, Tomoyuki Moriya

Int J Clin Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma.
Takahiro Einama, Shigeto Ueda, Hitoshi Tsuda, Kazuhiro Ogasawara, Kazuo Hatsuse

Exp Ther Med· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
Takashi Takeshita, Hitoshi Tsuda, Tomoyuki Moriya, Tamio Yamasaki, Hideki Asakawa, Shigeto Ueda

Ann Surg Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.
Darren Roblyer, Shigeto Ueda, Albert Cerussi, Wendy Tanamai, Amanda Durkin

Proc Natl Acad Sci U S A· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early reduction in standardized uptake value after one cycle of neoadjuvant chemotherapy measured by sequential FDG PET/CT is an independent predictor of pathological response of primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, Toshiaki Saeki, Akihiko Osaki, Takashi Shigekawa

Breast J· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis